CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03610893
NCT03610893N/ACompleted

A Randomized Comparison Between Perineural Dexamethasone and Perineural Dexmedetomidine as Adjuvants for Ultrasound-Guided Infraclavicular Blocks

University of Chile·interventional·Posted Aug 1, 2018·Updated May 1, 2019

In Brief

A clinical study evaluating Dexamethasone and Dexmedetomidine for Pain, Postoperative and 2 related conditions. Completed, enrolled 120 participants across 1 site.

Detailed Summary

When used as perineural (PN) adjuvants to local anesthetics (LAs), dexamethasone (DX) and dexmedetomidine (DXD) have been well documented to prolong the duration of peripheral nerve blocks. These drugs have important differences in terms of cost and safety profiles. This randomized controlled trial (RCT) will compare PN DX and PN DXD for ultrasound-guided infraclavicular brachial plexus blocks (ICBs). Since analgesic and sensory duration can be influenced by factors different to block, motor block duration is the main outcome. The protocol is designed as an equivalency trial and hypothesize that both drugs result in similar durations. The equivalency margin is set at 3 hrs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChile
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 1, 2018
Enrollment StartAug 16, 2018
Primary CompletionApr 30, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.9 years ago

Interventions

Dexamethasonedrug

Dexamethasone as perineural local anesthetic adjuvant

Dexmedetomidinedrug

Dexmedetomidine as perineural local anesthetic adjuvant